A non-interventional, post-authorization safety study (PASS) to evaluate long-term safety of anakinra (Kineret®) in patients with systemic juvenile idiopathic arthritis

First published 26/08/2019

Last updated 14/03/2024

EU PAS number:

EUPAS28378

Study

Finalised

Documents

Study protocol

Initial protocol

Sobi.ANAKIN-302 Clinical Study Protocol FINAL version 1 13 Mar 2019_Redacted

English (197.21 KB - PDF)View document

Study results

Sobi.ANAKIN-302 Clinical Study Report FINAL version 15 Nov 2019_Redacted

English (984.26 KB - PDF)View document

Study report

Other information

Secondary tabs